Overview of animal models of schizophrenia

Current Protocols in Neuroscience
Susan B Powell, Mark A Geyer

Abstract

Animal models of schizophrenia may increase the understanding of the neurological abnormalities associated with the disorder and aid in the development of rational pharmacological treatments. Rather than attempting to model the entire syndrome of schizophrenia, a more biologically oriented approach to animal models has been to focus on specific symptoms of schizophrenia that are more objectively measured in the clinical population and more directly translatable to animals (e.g., observables or endophenotypes). This overview focuses on behavioral measures that have been investigated in rodent models of schizophrenia with varying degrees of predictive, etiological, and construct validity. Because of the severity of cognitive deficits in schizophrenia and their resistance to current treatments, there is a need to develop animal models specific to the cognitive symptoms of schizophrenia. In light of this need, this overview discusses rodent models of cognition with relevance to the core cognitive deficits observed in schizophrenia.

References

Feb 1, 1979·Journal of Comparative and Physiological Psychology·C A Barnes
Aug 1, 1992·Pharmacology, Biochemistry, and Behavior·I Weiner, J Feldon
May 25, 1991·Lancet·E O'CallaghanR M Murray
Feb 1, 1991·Pharmacology, Biochemistry, and Behavior·J FeldonI Weiner
Oct 1, 1990·Electroencephalography and Clinical Neurophysiology·A S GevinsH R Jex
Jul 1, 1991·Archives of General Psychiatry·S E ArnoldA R Damasio
Jan 1, 1990·Progress in Brain Research·P S Goldman-Rakic
Jan 1, 1990·The Journal of Neuropsychiatry and Clinical Neurosciences·T E GoldbergD R Weinberger
Feb 1, 1990·Archives of General Psychiatry·D L Braff, M A Geyer
Jul 26, 1986·Lancet·M J Owen, S W Lewis
Jan 1, 1986·Progress in Brain Research·S Matthysse
May 1, 1988·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M A Geyer, G S Tapson
Aug 1, 1988·Pharmacology, Biochemistry, and Behavior·I WeinerJ Feldon
Nov 1, 1988·Behavioural Brain Research·A Ennaceur, J Delacour
Feb 1, 1988·Archives of General Psychiatry·S A MednickD Bonett
Jul 1, 1987·Archives of General Psychiatry·D R Weinberger
Jan 1, 1986·Progress in Neuro-psychopharmacology & Biological Psychiatry·P Willner
Mar 1, 1966·Archives of General Psychiatry·M H Orzack, C Kornetsky
Sep 1, 1966·Archives of General Psychiatry·M B Bowers, D X Freedman
May 1, 1984·Journal of Neuroscience Methods·R Morris
Jan 1, 1982·Psychophysiology·M A Geyer, D L Braff
Jan 1, 1982·Experimental Brain Research·G N BritoS I Gingold
Nov 1, 1981·Behavioural Brain Research·G N Brito, G J Thomas
Mar 27, 1995·Psychiatry Research·P W Corrigan, I B Addis
Jan 1, 1994·The Journal of Neuropsychiatry and Clinical Neurosciences·P S Goldman-Rakic
Dec 1, 1993·The American Journal of Psychiatry·K S CadenheadD L Braff
Aug 1, 1993·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·B K LipskaD R Weinberger

❮ Previous
Next ❯

Citations

Aug 27, 2009·Cellular and Molecular Life Sciences : CMLS·José L MorenoJavier González-Maeso
Jan 22, 2013·ACS Chemical Neuroscience·James B Hanks, Javier González-Maeso
Jan 30, 2015·Frontiers in Behavioral Neuroscience·Judith M ReichelCarsten T Wotjak
Aug 6, 2017·Molecular Neurobiology·Kristoffer SahlholmVíctor Fernández-Dueñas
Jun 12, 2013·The International Journal of Neuropsychopharmacology·José L Moreno, Javier González-Maeso

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.